Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.

Alexandrou ME, Papagianni A, Tsapas A, Loutradis C, Boutou A, Piperidou A, Papadopoulou D, Ruilope L, Bakris G, Sarafidis P.

J Hypertens. 2019 Dec;37(12):2307-2324. doi: 10.1097/HJH.0000000000002187.

PMID:
31688290
2.

Oral semaglutide for type 2 diabetes: a systematic review and meta-analysis.

Avgerinos I, Michailidis T, Liakos A, Karagiannis T, Matthews DR, Tsapas A, Bekiari E.

Diabetes Obes Metab. 2019 Oct 21. doi: 10.1111/dom.13899. [Epub ahead of print]

PMID:
31637820
3.

Guidelines for Medical Nutrition Therapy in Gestational Diabetes Mellitus: Systematic Review and Critical Appraisal.

Tsirou E, Grammatikopoulou MG, Theodoridis X, Gkiouras K, Petalidou A, Taousani E, Savvaki D, Tsapas A, Goulis DG.

J Acad Nutr Diet. 2019 Aug;119(8):1320-1339. doi: 10.1016/j.jand.2019.04.002. Epub 2019 Jun 11.

PMID:
31201104
4.

The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.

Piperidou A, Sarafidis P, Boutou A, Thomopoulos C, Loutradis C, Alexandrou ME, Tsapas A, Karagiannis A.

J Hypertens. 2019 Jul;37(7):1334-1343. doi: 10.1097/HJH.0000000000002050.

PMID:
31145707
5.

Prevention of orthodontic enamel demineralization: A systematic review with meta-analyses.

Tasios T, Papageorgiou SN, Papadopoulos MA, Tsapas A, Haidich AB.

Orthod Craniofac Res. 2019 Nov;22(4):225-235. doi: 10.1111/ocr.12322. Epub 2019 May 27. Review.

PMID:
31081584
6.

Performance of Baveno VI and Expanded Baveno VI Criteria for Excluding High-Risk Varices in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.

Stafylidou M, Paschos P, Katsoula A, Malandris K, Ioakim K, Bekiari E, Haidich AB, Akriviadis E, Tsapas A.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1744-1755.e11. doi: 10.1016/j.cgh.2019.04.062. Epub 2019 May 8. Review.

PMID:
31077823
7.

Carvedilol for prevention of variceal bleeding: a systematic review and meta-analysis.

Malandris K, Paschos P, Katsoula A, Manolopoulos A, Andreadis P, Sarigianni M, Athanasiadou E, Akriviadis E, Tsapas A.

Ann Gastroenterol. 2019 May-Jun;32(3):287-297. doi: 10.20524/aog.2019.0368. Epub 2019 Mar 12.

8.

Decreased cortisol response to low-dose Synacthen test in pediatric patients with type 1 diabetes.

Kalymniou M, Dimitriadou M, Slavakis A, Tsapas A, Galli-Tsinopoulou A, Christoforidis A.

J Diabetes. 2019 Sep;11(9):773-774. doi: 10.1111/1753-0407.12935. Epub 2019 May 8. No abstract available.

PMID:
31001876
9.

Intravenous Immunoglobulin for Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Manolopoulos A, Andreadis P, Malandris K, Avgerinos I, Karagiannis T, Kapogiannis D, Tsolaki M, Tsapas A, Bekiari E.

Am J Alzheimers Dis Other Demen. 2019 Aug;34(5):281-289. doi: 10.1177/1533317519843720. Epub 2019 Apr 15.

PMID:
30987435
10.

Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB.

Diabetologia. 2019 May;62(5):873. doi: 10.1007/s00125-019-4845-x.

PMID:
30899969
11.

Intravenous Magnesium Sulfate in Acute Stroke.

Avgerinos KI, Chatzisotiriou A, Haidich AB, Tsapas A, Lioutas VA.

Stroke. 2019 Apr;50(4):931-938. doi: 10.1161/STROKEAHA.118.021916.

PMID:
30852968
12.

Decision aids for people with Type 2 diabetes mellitus: an effectiveness rapid review and meta-analysis.

Karagiannis T, Andreadis P, Manolopoulos A, Malandris K, Avgerinos I, Karagianni A, Tsapas A.

Diabet Med. 2019 May;36(5):557-568. doi: 10.1111/dme.13939. Epub 2019 Mar 12. Review.

PMID:
30791131
13.

Successful Outcome of Hyperhemolysis in Sickle Cell Disease following Multiple Lines of Treatment: The Role of Complement Inhibition.

Vlachaki E, Gavriilaki E, Kafantari K, Adamidou D, Tsitsikas D, Chasapopoulou E, Anagnostopoulos A, Tsapas A.

Hemoglobin. 2018 Sep - Nov;42(5-6):339-341. doi: 10.1080/03630269.2018.1540353. Epub 2019 Jan 9.

PMID:
30626228
14.

Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life.

Paschos P, Katsoula A, Salanti G, Giouleme O, Athanasiadou E, Tsapas A.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1174-1185. doi: 10.1111/apt.15005. Epub 2018 Oct 30.

PMID:
30378141
15.

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB.

Diabetes Care. 2018 Dec;41(12):2669-2701. doi: 10.2337/dci18-0033. Epub 2018 Oct 4.

PMID:
30291106
16.

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB.

Diabetologia. 2018 Dec;61(12):2461-2498. doi: 10.1007/s00125-018-4729-5. Erratum in: Diabetologia. 2019 May;62(5):873.

PMID:
30288571
17.

Effect of liraglutide on ambulatory blood pressure in patients with hypertension and type 2 diabetes: A randomized, double-blind, placebo-controlled trial.

Liakos A, Lambadiari V, Bargiota A, Kitsios K, Avramidis I, Kotsa K, Gerou S, Boura P, Tentolouris N, Dimitriadis G, Tsapas A.

Diabetes Obes Metab. 2019 Mar;21(3):517-524. doi: 10.1111/dom.13541. Epub 2018 Oct 23.

PMID:
30242948
18.

Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis.

Paschos P, Katsoula A, Giouleme O, Sarigianni M, Liakos A, Athanasiadou E, Bekiari E, Tsapas A.

Ann Gastroenterol. 2018 Sep-Oct;31(5):572-582. doi: 10.20524/aog.2018.0276. Epub 2018 May 10.

19.

Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis.

Avgerinos I, Karagiannis T, Malandris K, Liakos A, Mainou M, Bekiari E, Matthews DR, Tsapas A.

Diabetes Obes Metab. 2019 Jan;21(1):188-193. doi: 10.1111/dom.13484. Epub 2018 Sep 3.

PMID:
30058208
20.

Comparative Benefits and Harms of Basal Insulin Analogues for Type 2 Diabetes: A Systematic Review and Network Meta-analysis.

Madenidou AV, Paschos P, Karagiannis T, Katsoula A, Athanasiadou E, Kitsios K, Bekiari E, Matthews DR, Tsapas A.

Ann Intern Med. 2018 Aug 7;169(3):165-174. doi: 10.7326/M18-0443. Epub 2018 Jul 10.

PMID:
29987326
21.

Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis.

Andreadis P, Karagiannis T, Malandris K, Avgerinos I, Liakos A, Manolopoulos A, Bekiari E, Matthews DR, Tsapas A.

Diabetes Obes Metab. 2018 Sep;20(9):2255-2263. doi: 10.1111/dom.13361. Epub 2018 Jun 10.

PMID:
29756388
22.

In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly exenatide ER.

Bekiari E, Karagiannis T, Tsapas A.

Ann Intern Med. 2018 Apr 17;168(8):JC46. doi: 10.7326/ACPJC-2018-168-8-046. No abstract available.

PMID:
29677253
23.

Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis.

Bekiari E, Kitsios K, Thabit H, Tauschmann M, Athanasiadou E, Karagiannis T, Haidich AB, Hovorka R, Tsapas A.

BMJ. 2018 Apr 18;361:k1310. doi: 10.1136/bmj.k1310. Review.

24.

Possible mechanisms of direct cardiovascular impact of GLP-1 agonists and DPP4 inhibitors.

Bistola V, Lambadiari V, Dimitriadis G, Ioannidis I, Makrilakis K, Tentolouris N, Tsapas A, Parissis J.

Heart Fail Rev. 2018 May;23(3):377-388. doi: 10.1007/s10741-018-9674-3. Review.

PMID:
29383638
25.

Cost-Effectiveness of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Greece.

Gourzoulidis G, Tzanetakos C, Ioannidis I, Tsapas A, Kourlaba G, Papageorgiou G, Maniadakis N.

Clin Drug Investig. 2018 May;38(5):417-426. doi: 10.1007/s40261-018-0620-x.

PMID:
29349708
26.

Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms.

Bougioukas KI, Liakos A, Tsapas A, Ntzani E, Haidich AB.

J Clin Epidemiol. 2018 Jan;93:9-24. doi: 10.1016/j.jclinepi.2017.10.002. Epub 2017 Oct 14. Review.

PMID:
29037888
27.

Evaluation of the Greek TranQol: a novel questionnaire for measuring quality of life in transfusion-dependent thalassemia patients.

Klonizakis P, Klaassen R, Sousos N, Liakos A, Tsapas A, Vlachaki E.

Ann Hematol. 2017 Nov;96(11):1937-1944. doi: 10.1007/s00277-017-3122-7. Epub 2017 Sep 7.

PMID:
28884221
28.

Meta-analysis of artificial pancreas trials: methodological considerations.

Bekiari E, Karagiannis T, Haidich AB, Tsapas A.

Lancet Diabetes Endocrinol. 2017 Sep;5(9):685. doi: 10.1016/S2213-8587(17)30261-9. No abstract available.

PMID:
28842161
29.

Quality of Life in Greek Patients with Autoimmune Bullous Diseases Assessed with ABQOL and TABQOL Indexes.

Patsatsi A, Kokolios M, Kyriakou A, Lamprou F, Stylianidou D, Tsapas A, Goulis DG, Murrell DF, Sotiriadis D.

Acta Derm Venereol. 2017 Oct 2;97(9):1145-1147. doi: 10.2340/00015555-2737.

30.

Diagnostic Accuracy of Fecal Immunochemical Test in Patients at Increased Risk for Colorectal Cancer: A Meta-analysis.

Katsoula A, Paschos P, Haidich AB, Tsapas A, Giouleme O.

JAMA Intern Med. 2017 Aug 1;177(8):1110-1118. doi: 10.1001/jamainternmed.2017.2309.

31.

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.

Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4. Review.

PMID:
28521870
32.

Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.

Stoimenis D, Karagiannis T, Katsoula A, Athanasiadou E, Kazakos K, Bekiari E, Matthews DR, Tsapas A.

Expert Opin Pharmacother. 2017 Jun;18(9):843-851. doi: 10.1080/14656566.2017.1324848. Epub 2017 May 9. Review.

PMID:
28448177
33.

Fixed ratio combinations of glucagon like peptide 1 receptor agonists with basal insulin: a systematic review and meta-analysis.

Liakopoulou P, Liakos A, Vasilakou D, Athanasiadou E, Bekiari E, Kazakos K, Tsapas A.

Endocrine. 2017 Jun;56(3):485-494. doi: 10.1007/s12020-017-1293-6. Epub 2017 Apr 12. Review.

PMID:
28401444
34.

Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy.

Karagiannis T, Bekiari E, Tsapas A.

Core Evid. 2017 Mar 15;12:1-10. doi: 10.2147/CE.S109654. eCollection 2017. Review.

35.

Use of the Diabetes Medication Choice Decision Aid in patients with type 2 diabetes in Greece: a cluster randomised trial.

Karagiannis T, Liakos A, Branda ME, Athanasiadou E, Mainou M, Boura P, Goulis DG, LeBlanc A, Montori VM, Tsapas A.

BMJ Open. 2016 Nov 14;6(11):e012185. doi: 10.1136/bmjopen-2016-012185.

36.

Association between response rates and survival outcomes in patients with newly diagnosed multiple myeloma. A systematic review and meta-regression analysis.

Mainou M, Madenidou AV, Liakos A, Paschos P, Karagiannis T, Bekiari E, Vlachaki E, Wang Z, Murad MH, Kumar S, Tsapas A.

Eur J Haematol. 2017 Jun;98(6):563-568. doi: 10.1111/ejh.12868. Epub 2017 Mar 20. Review.

PMID:
28178364
37.

Antigen-based immunotherapies do not prevent progression of recent-onset autoimmune diabetes: a systematic review and meta-analysis.

Rizava C, Bekiari E, Liakos A, Sarigianni M, Rika M, Haidich AB, Galli-Tsinopoulou A, Tsapas A.

Endocrine. 2016 Dec;54(3):620-633. doi: 10.1007/s12020-016-1033-3. Epub 2016 Jul 29. Review.

PMID:
27473096
38.

Investigating the role of Natural Killer T-cells in Gram negative infections of patients with type 2 diabetes mellitus.

Karagianni P, Polyzos SA, Bougiouklis D, Tsapas A, Paletas K.

Hippokratia. 2015 Jul-Sep;19(3):231-4.

39.

Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.

Karagiannis T, Bekiari E, Boura P, Tsapas A.

Ther Adv Drug Saf. 2016 Apr;7(2):36-8. doi: 10.1177/2042098615623915. Epub 2015 Dec 23. No abstract available.

40.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Sarafidis PA, Tsapas A.

N Engl J Med. 2016 Mar 17;374(11):1092. doi: 10.1056/NEJMc1600827. No abstract available.

PMID:
26981941
41.

A systematic review and meta-analysis of off-loading methods for diabetic foot ulcers.

Elraiyah T, Prutsky G, Domecq JP, Tsapas A, Nabhan M, Frykberg RG, Firwana B, Hasan R, Prokop LJ, Murad MH.

J Vasc Surg. 2016 Feb;63(2 Suppl):59S-68S.e1-2. doi: 10.1016/j.jvs.2015.10.006. Review.

42.

A systematic review and meta-analysis of adjunctive therapies in diabetic foot ulcers.

Elraiyah T, Tsapas A, Prutsky G, Domecq JP, Hasan R, Firwana B, Nabhan M, Prokop L, Hingorani A, Claus PL, Steinkraus LW, Murad MH.

J Vasc Surg. 2016 Feb;63(2 Suppl):46S-58S.e1-2. doi: 10.1016/j.jvs.2015.10.007. Review.

43.

A systematic review and meta-analysis of débridement methods for chronic diabetic foot ulcers.

Elraiyah T, Domecq JP, Prutsky G, Tsapas A, Nabhan M, Frykberg RG, Hasan R, Firwana B, Prokop LJ, Murad MH.

J Vasc Surg. 2016 Feb;63(2 Suppl):37S-45S.e1-2. doi: 10.1016/j.jvs.2015.10.002. Review.

44.

A systematic review and meta-analysis of tests to predict wound healing in diabetic foot.

Wang Z, Hasan R, Firwana B, Elraiyah T, Tsapas A, Prokop L, Mills JL Sr, Murad MH.

J Vasc Surg. 2016 Feb;63(2 Suppl):29S-36S.e1-2. doi: 10.1016/j.jvs.2015.10.004. Review.

45.

A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome.

Hasan R, Firwana B, Elraiyah T, Domecq JP, Prutsky G, Nabhan M, Prokop LJ, Henke P, Tsapas A, Montori VM, Murad MH.

J Vasc Surg. 2016 Feb;63(2 Suppl):22S-28S.e1-2. doi: 10.1016/j.jvs.2015.10.005. Review.

46.

Systematic review and meta-analysis of vildagliptin for treatment of type 2 diabetes.

Bekiari E, Rizava C, Athanasiadou E, Papatheodorou K, Liakos A, Karagiannis T, Mainou M, Rika M, Boura P, Tsapas A.

Endocrine. 2016 Jun;52(3):458-80. doi: 10.1007/s12020-015-0841-1. Epub 2015 Dec 29. Review.

PMID:
26714458
47.

Premixed insulin regimens for type 2 diabetes.

Tsapas A, Karagiannis T, Bekiari E.

Endocrine. 2016 Mar;51(3):387-9. doi: 10.1007/s12020-015-0821-5. Epub 2015 Dec 9. No abstract available.

PMID:
26649859
48.

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

Karagiannis T, Liakos A, Bekiari E, Athanasiadou E, Paschos P, Vasilakou D, Mainou M, Rika M, Boura P, Matthews DR, Tsapas A.

Diabetes Obes Metab. 2015 Nov;17(11):1065-74. doi: 10.1111/dom.12541. Epub 2015 Sep 23. Review.

PMID:
26395850
49.

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia.

Liakos A, Athanasiadou E, Mainou M, Bekiari E, Haidich AB, Rizos EC, Tsapas A.

Ann Intern Med. 2015 Aug 4;163(3):241. doi: 10.7326/L15-5118. No abstract available.

PMID:
26237757
50.

Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus.

Liakos A, Karagiannis T, Bekiari E, Boura P, Tsapas A.

Ther Adv Endocrinol Metab. 2015 Apr;6(2):61-7. doi: 10.1177/2042018814560735. Review.

Supplemental Content

Loading ...
Support Center